Announcements

Announcements
 
 
Paul G. Allen Frontiers Group    [to 9 Feb 2019]
https://www.alleninstitute.org/news-press/
No new digest content identified.
 
 
BMGF – Gates Foundation  [to 9 Feb 2019]
http://www.gatesfoundation.org/Media-Center/Press-Releases
No new digest content identified.
 
 
Bill & Melinda Gates Medical Research Institute    [to 9 Feb 2019]
https://www.gatesmri.org/
The Bill & Melinda Gates Medical Research Institute is a non-profit biotech organization. Our mission is to develop products to fight malaria, tuberculosis, and diarrheal diseases—three major causes of mortality, poverty, and inequality in developing countries. The world has unprecedented scientific tools at its disposal; now is the time to use them to save the lives of the world’s poorest people
No new digest content identified.
 
 
CARB-X   [to 9 Feb 2019]
https://carb-x.org/
CARB-X is a non-profit public-private partnership dedicated to accelerating antibacterial research to tackle the global rising threat of drug-resistant bacteria.
02.06.2019  |
CARB-X funds Recida Therapeutics to develop a new class of antibiotics to treat deadly infections caused by Gram-negative superbugs
Recida’s new LpxC inhibitor is a potential treatment for multidrug-resistant Enterobacteriaceae
 
 
02.04.2019  |
CARB-X funds Polyphor to develop a new class of antibiotics to treat serious infections caused by Gram-negative ESKAPE superbugs
CARB-X, a Boston University global partnership, is awarding Polyphor (SIX: POLN) of Allschwil, Switzerland, up to $2.6 million in non-dilutive funding with the possibility of $3.0 million more if certain project milestones are met, to develop a novel antibiotic with a novel mode of action to treat serious infections caused by Gram-negative ESKAPE pathogens.
 
 
CEPI – Coalition for Epidemic Preparedness Innovations  [to 9 Feb 2019]
http://cepi.net/
No new digest content identified.
 
 
EDCTP    [to 9 Feb 2019]
http://www.edctp.org/
The European & Developing Countries Clinical Trials Partnership (EDCTP) aims to accelerate the development of new or improved drugs, vaccines, microbicides and diagnostics against HIV/AIDS, tuberculosis and malaria as well as other poverty-related and neglected infectious diseases in sub-Saharan Africa, with a focus on phase II and III clinical trials
Latest news
No new digest content identified.
 
 
Emory Vaccine Center    [to 9 Feb 2019]
http://www.vaccines.emory.edu/
No new digest content identified.
 
 
European Medicines Agency  [to 9 Feb 2019]
http://www.ema.europa.eu/ema/
News and press releases
No new digest content identified.
 
 
European Vaccine Initiative  [to 9 Feb 2019]
http://www.euvaccine.eu/news-events
Latest news
No new digest content identified.
 
 
FDA [to 9 Feb 2019]
https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/default.htm
February 07, 2019 –
FDA takes new steps to adopt more modern technologies for improving the security of the drug supply chain through innovations that improve tracking and tracing of medicines
… As part of these efforts, today, the agency is launching a new pilot project in which participants representing the drug supply chain (e.g., manufacturers, repackagers and other stakeholders) can pilot the use of innovative and emerging approaches for enhanced tracing and verification of prescription drugs in the U.S. to ensure suspect and illegitimate products do not enter the supply chain…
 
Fondation Merieux  [to 9 Feb 2019]
http://www.fondation-merieux.org/
Partner event
4th Meeting of the Global Task Force on Cholera Control (GTFCC) – WASH Working Group
February 12 – 13, 2019 – Les Pensières Center for Global Health, Veyrier du Lac (France)
 
Gavi [to 9 Feb 2019]
https://www.gavi.org/
No new digest content identified.
 
GHIT Fund   [to 9 Feb 2019]
https://www.ghitfund.org/newsroom/press
GHIT was set up in 2012 with the aim of developing new tools to tackle infectious diseases that devastate the world’s poorest people. Other funders include six Japanese pharmaceutical
No new digest content identified.
 
Global Fund  [to 9 Feb 2019]
https://www.theglobalfund.org/en/news/
News
Global Partners Commit to Step Up the Fight Against AIDS, TB and Malaria
08 February 2019
At the kick-off meeting of the Global Fund’s Sixth Replenishment, leaders, global health organizations, civil society groups and people affected by the diseases vowed collective action to end the epidemics of AIDS, tuberculosis and malaria and accelerate progress toward universal health coverage….
 
News
Significant Progress Achieved Against TB in High-Burden Asian Countries
07 February 2019
NEW DELHI – Preliminary results from a joint initiative to find and treat additional 1.5 million “missing” tuberculosis patients by the end of 2019 show solid progress, with Asia driving the success. Six countries in Asia with the highest burdens of TB in the world have found an additional 450,000 cases of TB in the past year alone, and more than 840,000 additional patients compared with 2015.
Half of the additional TB cases found last year through the initiative, which is supported by the Global Fund, World Health Organization and the Stop TB Partnership, were in India alone…
 
Hilleman Laboratories   [to 9 Feb 2019]
http://www.hillemanlabs.org/
No new digest content identified.
 
Human Vaccines Project   [to 9 Feb 2019]
http://www.humanvaccinesproject.org/media/press-releases/
February 02, 2019
New European Foundation for the Human Vaccines Project
To expand our global reach, we have established a new nonprofit foundation in The Netherlands: Human Vaccines Project Europe. We are seeking to develop a European network of researchers and research institutions to bolster our global effort to decode the human immune system. This European foundation will support the global objective through outreach, advocacy, and resource mobilization.
Frans van den Boom is Director of the European foundation, and Nadia Rozendaal is Senior Advisor.
 
IAVI  [to 9 Feb 2019]
https://www.iavi.org/newsroom
No new digest content identified.
 
IFFIm
http://www.iffim.org/library/news/press-releases/
No new digest content identified.
 
IVAC  [to 9 Feb 2019]
https://www.jhsph.edu/research/centers-and-institutes/ivac/index.html
February 2019
Dr. Naor Bar-Zeev appointed as the new deputy director of IVAC
The International Vaccine Access Center (IVAC) is pleased to announce that Naor Bar-Zeev, MBBS(Hons), MPH, MBiostat, PhD, has been appointed as the new deputy director of IVAC. Naor joined the IVAC team in 2017 as an Associate Professor in the Department of International Health at the Johns Hopkins Bloomberg School of Public Health.
 
IVI   [to 9 Feb 2019]
http://www.ivi.int/
IVI News & Announcements
No new digest content identified.
 
JEE Alliance  [to 9 Feb 2019]
https://www.jeealliance.org/
Selected News and Events
Mali – A Multi-sectoral and Multi-stakeholder Cooperation Success Story
8.2.2019  Article
Disease outbreaks continue to occur in Mali and the ongoing security crisis highlights the importance of a comprehensive national framework for health security…
 
 
MSF/Médecins Sans Frontières  [to 9 Feb 2019]
http://www.msf.org/
Selected News; Project Updates, Reports [as presented on website]
Access to medicines
TB activists challenge patent in India, in bid to prevent J&J from exte…
Press Release 8 Feb 2019
 
Democratic Republic of Congo
Ten thousand people living in desperate conditions in northeas…
Project Update 7 Feb 2019
 
Refugees, IDPs and people on the move
Nine countries and 7,000km; Asad’s journey from Somalia to Europe
Voices from the Field 6 Feb 2019
 
France
Migrants trapped in relentless cycle of rejection on French-Spa…
Project Update 6 Feb 2019
 
Yemen
Unacceptable investigation findings into Abs health centre b…
Press Release 6 Feb 2019

Rohingya refugee crisis
The 5 things we’ve found after one million consultations in Cox’s …
Project Update 5 Feb 2019
 
NIH  [to 9 Feb 2019]
http://www.nih.gov/news-events/news-releases
February 8, 2019
Acyclovir labeling now includes details for treating premature infants infected with herpes virus
— NIH-funded study provides information on drug’s dosing and use in newborns.
 
Mega docking library poised to speed drug discovery
February 6, 2019 — One billion-plus compounds – weeded of “decoys” – expected by 2020.
 
PATH  [to 9 Feb 2019]
https://www.path.org/media-center/
No new digest content identified.
 
Sabin Vaccine Institute  [to 9 Feb 2019]
http://www.sabin.org/updates/pressreleases
No new digest content identified.
 
UNAIDS [to 9 Feb 2019]
http://www.unaids.org/en
Selected Press Releases/Reports/Statements
8 February 2019
Global Fund presents its Sixth Investment Case in New Delhi
 
7 February 2019
United Kingdom pledges to end HIV transmission in the country within 10 years
 
6 February 2019
Reducing harm for women who inject drugs in Myanmar
 
4 February 2019
It’s time to make cervical cancer history
 
UNICEF  [to 9 Feb 2019]
https://www.unicef.org/media/press-releases
Selected Press Releases/Reports/Statements
Statement
Two children killed in the Gaza Strip
Statement attributable to Geert Cappelaere, UNICEF Regional Director for the Middle East and North Africa
09/02/2019
 
Press release
Over 160,000 displaced children protected from harsh winter in Iraq
06/02/2019
 
Press release
Only one third of children covered by social protection: ILO, UNICEF
A new report by UNICEF and the ILO highlights the critical need to extend social protection to all children
06/02/2019
 
Statement
Take action to eliminate female genital mutilation by 2030
Joint statement by Henrietta Fore, UNICEF Executive Director, Dr. Natalia Kanem, UNFPA Executive Director, and Phumzile Mlambo-Ngcuka, UN Women Executive Director
05/02/2019
 
Press release
Safer Internet Day: UNICEF calls for concerted action to prevent bullying and harassment for the over 70 per cent of young people online worldwide
Thirty years after the adoption of the Convention on the Rights of the Child and the creation of the World Wide Web, it’s time for renewed focus on children’s digital rights
04/02/2019
 
 
Vaccine Confidence Project  [to 9 Feb 2019]
http://www.vaccineconfidence.org/
Posted on 20 Jan, 2019
WHO announces Top Ten Threats to Global Health in 2019
In its 2019 new year message, WHO has named vaccine hesitancy as one of the world’s top 10 global health threats, alongside air pollution and climate change, noncommunicable diseases, global influenza pandemic, fragile and vulnerable settings, antimicrobial resistance,  Ebola and other high-threat
 
Vaccine Education Center – Children’s Hospital of Philadelphia  [to 9 Feb 2019]
http://www.chop.edu/centers-programs/vaccine-education-center
No new digest content identified.
 
Wellcome Trust  [to 9 Feb 2019]
https://wellcome.ac.uk/news
Wellcome Trust | 8 February 2019
Jeremy Farrar reflects on his trip to the Ebola outbreak in the DRC
 
News | 4 February 2019
New funding to boost global research capacity in humanities and social science
We’re launching two new calls to fund international exchange networks and infrastructure costs for humanities and social science researchers around the world.
 
The Wistar Institute   [to 9 Feb 2019]
https://www.wistar.org/news/press-releases
Press Release    Feb. 7, 2019
Engineered DNA Vaccine Protects Against Emerging Mayaro Virus Infection
New vaccine induces robust and specific immune responses and provides complete protection from disease in preclinical studies.
 
World Organisation for Animal Health (OIE)   [to 9 Feb 2019]
http://www.oie.int/en/for-the-media/press-releases/2018/
No new digest content identified.
 
::::::
 
 
BIO    [to 9 Feb 2019]
https://www.bio.org/insights/press-release
Feb 7 2019
BIO Encouraged by Improved U.S. Ranking in Global Index of Patent System Strength
But New Legislative Proposals Endanger Progress
 
 
DCVMN – Developing Country Vaccine Manufacturers Network  [to 9 Feb 2019]
http://www.dcvmn.org/
No new digest content identified.
 
 
IFPMA   [to 9 Feb 2019]
http://www.ifpma.org/resources/news-releases/
No new digest content identified.
 
 
PhRMA    [to 9 Feb 2019]
http://www.phrma.org/press-room
February 8, 2019     Press Release
PhRMA Decries Damaging Foreign Practices in Special 301 Filing
WASHINGTON, D.C. (February 8, 2019) – The Pharmaceutical Research and Manufacturers of America (PhRMA) today urged the Office of the United States Trade Representative (USTR) to take immediate action to address serious and growing market access and intellectual property barriers in top overseas markets.
In its submission for USTR’s annual Special 301 Report, PhRMA called on the Trump administration to name Canada, Japan, Korea and Malaysia as “Priority Foreign Countries” – a designation reserved for countries with the worst market access barriers and the most damaging intellectual property practices.
“When foreign countries impose trade barriers and fail to value new inventions, they threaten U.S. manufacturing and jobs,” said PhRMA Senior Vice President for International Advocacy Brian Toohey. “Damaging price controls in Canada, Japan, Korea and many other countries are jeopardizing American exports and limiting access to new medicines.”…